Related Experiment Video

Updated: Oct 18, 2026

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

The intra-aortic cannula pump: A novel assist device for the acutely failing heart

R Sharony1, E Porat, Y Nishimura

  • 1Department of Cardiothoracic Surgery, Carmel Medical Center, Rappaport Institute, Faculty of Medicine, Technion-IIT, Haifa, Israel. sharonyr@tx.technion.ac.il

Insights

The intra-aortic cannula pump effectively supports acutely failing hearts by improving cardiac output and reducing left atrial pressure. This new device shows promise for treating moderate to severe heart failure.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Critical Care

Background:

  • Acute heart failure presents a critical challenge in cardiovascular medicine.
  • Existing treatments for acute heart failure have limitations.
  • Novel intracardiac support systems are needed to improve patient outcomes.

Purpose of the Study:

  • To evaluate the hemodynamic performance of a novel intra-aortic cannula pump.
  • To assess the efficacy of this device in supporting the acutely failing heart.
  • To analyze its impact on key hemodynamic parameters in different stages of heart failure.

Main Methods:

  • A 24F intra-aortic cannula pump was tested in a sheep model (n=16).
  • Heart failure was induced using microsphere injection into the left anterior descending coronary artery.
  • Hemodynamic parameters were measured in nonfailing, moderately failing, and severely failing hearts.

Main Results:

  • Cannula insertion was technically feasible in all subjects.
  • The device significantly increased cardiac output in moderately and severely failing hearts (p < .001).
  • Left atrial pressure decreased, and systemic blood pressure increased in severe heart failure (p < .001).

Conclusions:

  • The intra-aortic cannula pump demonstrates significant hemodynamic benefits in moderate and severe acute heart failure.
  • This device represents a promising new therapeutic option for acute heart failure.
  • Further clinical investigation is warranted to confirm these findings in human patients.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...